Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques
Atherosclerosis is a chronic long-lasting vascular disease leading to myocardial infarction and stroke. Vulnerable atherosclerotic (AS) plaques are responsible for these life-threatening clinical endpoints. To more successfully work against atherosclerosis, improvements in early diagnosis and treatm...
Main Authors: | Harald Mangge, Gunter Almer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/17/3072 |
Similar Items
-
Beyond Macrophages and T Cells: B Cells and Immunoglobulins Determine the Fate of the Atherosclerotic Plaque
by: Harald Mangge, et al.
Published: (2020-06-01) -
Sodium Danshensu stabilizes atherosclerotic vulnerable plaques by targeting IKKβ mediated inflammation in macrophages
by: Miao Zeng, et al.
Published: (2023-09-01) -
Biomarkers of atherosclerotic plaque vulnerability and their clinical significance
by: Ran LIU, et al.
Published: (2016-09-01) -
The Elusive Origin of Atherosclerotic Plaque Calcification
by: Emmanuelle Canet-Soulas, et al.
Published: (2021-03-01) -
Calcification in Atherosclerotic Plaque Vulnerability: Friend or Foe?
by: Xuan Shi, et al.
Published: (2020-02-01)